Browse > Article

Platinum Transporters and Drug Resistance  

Choi, Min-Koo (Department of Pharmaceutics, College of Pharmacy, Seoul National University)
Kim, Dae-Duk (Department of Pharmaceutics, College of Pharmacy, Seoul National University)
Publication Information
Archives of Pharmacal Research / v.29, no.12, 2006 , pp. 1067-1073 More about this Journal
Abstract
Cisplatin, a platinum coordinated complex, is a widely used antineoplastic agent for the treatment of metastatic tumors of the testis, metastatic ovarian tumors, lung cancer, advanced bladder cancer and many other solid tumors. The cytotoxic action of the drug is often thought to be associated with its ability to bind DNA to form cisplatin-DNA adducts. The development of resistance to cisplatin during treatment is common and constitutes a major obstacle to the cure of sensitive tumors. Although to understand the clinically relevant mechanisms of resistance, many studies have been aimed at clarifying the biochemical/molecular alterations of cisplatin-resistance cells, these studies did not conclusively identify the basis of cellular resistance to cisplatin. In this review, cisplatin resistance was discussed in terms of the relevant transporters, such as copper transporters (CTRs), organic cation transporters (OCTs) and multi-drug resistance related transporters (MDRs). These transporters seem to be contributed to cisplatin resistance through the reduction of drug accumulation in the cell. Better understanding the mechanism of cisplatin resistance associated with transporters will provide the useful informations for overcoming the cisplatin resistance.
Keywords
Cisplatin; Resistance; Transporters; CTRs; OCTs; MDRs;
Citations & Related Records

Times Cited By Web Of Science : 11  (Related Records In Web of Science)
Times Cited By SCOPUS : 10
연도 인용수 순위
1 Andrews, P. A. and Howell, S. B., Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells, 2, 35-43 (1990)
2 Cole, S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G., Pharmacological characterization of multidrug resistant MP-transfected human tumor cells. Cancer Res., 54, 5902-5910 (1994)
3 Dancis, A., Haile, D., Yuan, D. S., and Klausner, R. D., The saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake. J. Biol. Chem., 269, 25660- 25667 (1994)
4 Eisses, J. F. and Kaplan, J. H., Molecular characterization of hCtr1, the human copper uptake protein. J. Biol. Chem., 277, 29162-29171 (2002)   DOI   ScienceOn
5 Fink, D., Aebi, S., and Howell, S.B., The role of DNA mismatch repair in drug resistance. Clin. Cancer Res., 4, 1-6 (1998)
6 Gately, D. P. and Howell, S. B., Cellular accumulation of the anticancer agent cisplatin: a review. Br. J. Cancer., 67, 1171- 1176 (1993)   DOI   ScienceOn
7 Giaccone, G., Clinical perspectives on platinum resistance. Drugs, 59, 9-17 (2000)
8 Guo, Y., Smith, K., Lee, J., Thiele, D. J., and Patris, M. J., Identification of methionine-rich clusters that regulate copperstimulated endocytosis of the human Ctr1 copper transporter. J. Biol. Chem., 279, 17428-17483 (2004a)   DOI   ScienceOn
9 Guo, Y., Smith, K., and Petris, M. J., Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: Requirement for the extracellular methionine-rich clusters. J. Biol. Chem., 279, 46393-46399 (2004b)   DOI   ScienceOn
10 Kanzaki, A., Toi, M., Neamati, N., Miyashita, H., Oubu, M., Nakayama, K., Bando, H., Ogawa, K., Mutoh, M., Mori, S., Terada, K., Sugiyama, T., Fukumoto, M., and Takebayashi, Y., Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma. Jpn. J. Cancer Res., 93, 70-77 (2002)   DOI
11 Katano, K., Safaei, R., Samimi, G., Holzer, A., Rochdi, M., and Howell, S.B., The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol. Pharmacol., 64, 466-473 (2003)   DOI   ScienceOn
12 Kuo, Y. M., Zhou, B., Cossco, D., and Gitschier, J., The copper transporter CTR1 provides and essential function in mammalian embryonic development. Proc. Natl. Acad. Sci. U.S.A., 98, 6836-6841 (2001)
13 Lai, G. M., Ozols, R. F., Young, R. C., and Hamilton, T. C., Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J. Natl. Cancer Inst., 81, 535-539 (1989)   DOI
14 Lee, J., Prohaska, J. R., Dagenais, S. L., Glover, T. W., and Thiele, D. J., Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant. Gene, 254, 87-96 (2000)   DOI   ScienceOn
15 Lin, X., Okuda, T., Holzer, A., and Howell, S. B., The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol. Pharmacol., 62, 1154–1159 (2002)   DOI   ScienceOn
16 Ryoyano, A., Fernandez, C., Sancho, P., de Blas, E., and Aller, P., Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation. J. Biol. Chem., 276, 47105- 17115 (2001)
17 Lokich, J. and Anderson, N., Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol., 9, 13- 21 (1998)   DOI   ScienceOn
18 Minamino, T., Tamai, M., Itoh, Y., Tatsumi, Y., Nomura, M., Yokogawa, K., Suzuki, H., Sugiyama, Y., Ohshima, T., and Miyamoto, K., In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT). Jpn. J. Cancer Res., 90, 1171-1178 (1999)   DOI
19 Okuda, M., Tsuda, K., Masaki, K., Hashimoto, Y., and Inui, K., Cisplatin-induced toxicity in LLC-PK1 kidney epithelial cells: role of basolateral membrane transport. Toxicol. Lett., 106, 229–235 (1999)   DOI   ScienceOn
20 Safaei, R. and Howell, S. B., Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit. Rev. Oncol. Hematol., 53, 13-23 (2005)   DOI   ScienceOn
21 Siddik, Z. H., Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 22, 7265-7279 (2003)   DOI   ScienceOn
22 Weiss, R. B., and Christian, M. C., New cisplatin analogues in development. Drugs, 46, 360-377 (1993)   DOI   ScienceOn
23 Yao, K. S., Godwin, A. K., Johnson, S. W., Ozols, R. F., O'Dwyer, P. J., and Hamilton, T. C., Evidence for altered regulation of gamma-glutamylcystein gene expression among cisplatinsensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res., 55, 4367-4374 (1995)
24 Siddik, Z. H., Biochemical and molecular mechanisms of cisplatin resistance. Cancer Treat Res., 112, 263-284 (2002)
25 de Jongh, F. E., van Veen, R. N., Veltman, S. J., de Wit, R., van der Burg, M. E., van den Bent, M. J., Planting, A. S., Graveland, W. J., Stoter, G., and Verweij, J., Weekly highdose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br. J. Cancer, 88, 1199-1206 (2003)   DOI   ScienceOn
26 Katano, K., Kondo, A., Safaei, R., Holzer, A., Samimi, G., Mishima, M. Kuo, Y. M., Rochdi, M., and Howell, S. B., Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of Copper. Cancer Res., 62, 6559-6565 (2002)
27 Helleman, J., Burger, H., Hamelers, I. H., Boersma, A. W., de Kroon, A. I., Stoter, G., and Nooter, K., Impaired Cisplatin Influx in an A2780 Mutant Cell Line: Evidence for a Putative, Cis-Configuration-Specific, Platinum Influx Transporter. Cancer Biol. Ther., (2006). In press
28 Lee, J., Pena, M. M., Nose, Y., and Thiele, D. J., Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem., 277, 4380-4387 (2002)   DOI   ScienceOn
29 Valentine, J. S. and Gralla, E. B., Delivering copper inside yeast and human cells. Science, 278, 817-818 (1997)   DOI   ScienceOn
30 Ichimura, T., Hung, C. C., Yang, S. A., Stevens, J. L., and Bonventre, J. V., Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol., 286, F552-F553 (2004)   DOI
31 Schroder, C. P., Godwin, A. K., O'Dwyer, P. J., Tew, K. D., Hamilton, T. C., and Ozols, R. F., Glutathione and drug resistance. Cancer Invest., 14,158-168 (1996)   DOI
32 Meijer, C., Mulder, N. H., Timmer-Bosscha, H., Sluiter, W. J., Meersma, G. J., and de Vries, E. G., Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res., 52, 6885-6889 (1992)
33 Eisses, J. F. and Kaplan, J. H., The mechanism of copper uptake mediated by human CTR1: a mutational analysis. J. Biol. Chem., 280, 37159-37168 (2005)   DOI   ScienceOn
34 Ikuta, K., Takemura, K., Sasaki, K., Kihara, M., Nishimura, M., Ueda, N., Naito, S., Lee, E., Shimizu, E., and Yamauch, A., Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells. Biol. Pharm. Bull., 28, 707-712 (2005)   DOI   ScienceOn
35 Johnson, S. W., Laub, P. B., Beesley, J. S., Ozols, R. F., and Hamilton, T. C., Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res., 57, 850-856 (1997)
36 Culotta, V. C., Klomp, L. W., Strain, J., Casareno, R. L., Krems, B., and Gitlin, J. D., The copper chaperone for superoxide dismutase. J. Biol. Chem., 272, 23469-23472 (1997)   DOI   ScienceOn
37 Raymond, E., Faivre, S., Chaney, S., Woynarowski, J., and Cvitkovic, E., Cellular and molecular pharmacology of oxaliplatin. Mol. Cancer. Ther., 1, 227-235 (2002)
38 Jansen, B. A., Brouwer, J., and Reedijk, J., Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J. Inorg. Biochem., 89, 197-202 (2002)   DOI   ScienceOn
39 Ishida, S., Lee, J., Thiele, D. J., and Herskowitz, I., Uptake of the anticancer drug cisplatin mediated by copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci., 99, 14298-14302 (2002)
40 Ludwig, T., Riethmuller, C., Gekle, M., Schwerdt, G., and Oberleithner, H., Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int., 66, 196-202 (2004)   DOI   ScienceOn
41 Urakami, Y., Okuda, M., Masuda, S., Saito, H., and Inui, K., Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J. Pharmacol. Exp. Ther., 287, 800-805 (1998)
42 Masters, J. R., Thomas, R., Hall, A. G., Hogarth, L., Matheson, E. C., Cattan, A. R., Lohrer, A. R., and Lohrer, H., Sensitivity of testis tumor cells to chemotherapeutic drugs: role of detoxifying pathways. Eur. J. Cancer, 32A,1248-1253 (1996)
43 Prestayko, A. W., D'Aoust, J. C., Issell, B. F., and Crook, S. T., Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat. Rev., 6, 17-39 (1979)   DOI   ScienceOn
44 Kollmannsberger, C., Nichols, C., and Bokemeyer, C., Recent advances in management of patients with platinum-refractory testicular germ cell tumors. Cancer, 106, 1217-1226 (2006)   DOI   ScienceOn
45 Sasada, T., Nakamura, H., Ueda, S., Iwata, S., Ueno, M., Takabayashi, A., and Yodoi, J., Secretion of thioredoxin enhznces cellular resistance to cis-diamminedichloroplatinum (II). Antioxid. Redox. Signal., 2, 695-705 (2000)   DOI   ScienceOn
46 Thadhani, R., Pascual, M., and Bonventre, J. V., Acute renal failure. N. Engl. J. Med., 334, 1448-1460 (1996)   DOI   ScienceOn
47 Lee, J., Prohaska, J. R., and Thiele, D. J., Essential role for mammalian copper transporter Ctr1 in copper homeostasis ans embryonic development. Proc. Natl. Acad. Sci. U.S.A., 98, 6842-6847 (2001)
48 Nakayama, K., Kanazaki, A., Ogawa, K., Miyazaki, K., Neamati, N., and Takebayashi, Y., Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP, and BCRP. Int. J. Cancer, 101, 488-495 (2002)   DOI   ScienceOn
49 Culotta, V. C., Lin, S. J., Schmidt, P., Klomp, L.W., Casareno, R. L., and Gitlin, J., Intracellular pathways of copper trafficking in yeast and humans. Adv. Exp. Med. Biol., 448, 247-254 (1999)
50 Ishikawa, T. and Ali-Osmann, F., Glutathione-associated cisdiamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J. Biol. Chem., 268, 20116-20125 (1993)
51 Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z. S., Terada, K., Furukawa, T., Yang, X. L., Gao, H., Miura, N., Sugiyama, T., and Akiyama, S., Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res., 60, 1312-1316 (2000)
52 Puig, S. and Thiele, D. J., Molecular mechanisms of copper uptake and distribution. Curr. Opin. Chem. Biol., 6, 171-180 (2002)   DOI   ScienceOn
53 Petris, M. J., Smith, K., Lee, J., and Thieles, D. J., Copperstimulated endocytosis and degradation of the human copper transporter, hCtr1. J. Biol. Chem., 278, 9639-9646 (2003)   DOI   ScienceOn
54 Holzer, A. K., Katano, K., Klomp, L. W., and Howell, S. B., Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clin. Cancer Res., 10, 6744-6749 (2004)   DOI   ScienceOn
55 Amaravadi, R., Glerum, D. M., and Tzagoloff, A., Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment. Hum. Genet., 99, 329-333 (1997)   DOI
56 Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., and Anderson, M. E., High resistance to cisplatin in human ovarian cancer cells is associated with marked increae of glutathione synthesis. Proc. Natl. Acad. Sci., 89, 3070-3074 (1992)
57 Samimi, G., Varki, N. M., Wilczynski, S., Safaei, R., Alberts, D. S., and Howell, S. B., Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin. Cancer Res., 9, 5853-5859 (2003)
58 Yonezawa, A., Satohiro, M., Nishihara, K., Yano, I., Katsura, T., and Inui, K. I., Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biolchem. Pharmacol., 70, 1823-1831 (2005)   DOI   ScienceOn
59 Dedoussis, G. V., and Andrikopoulos, N. K., Glutathionine depletion restores the susceptibility of cisplatin-resistant chronic myelogenous leukemia cell lines to natural killer cellmediated cells via necrosis rather than apoptosis. Eur. J. Cell. Biol., 89, 608-614 (2001)
60 Eisses, J. F., Chi, Y., and Kaplan, J. H., Stable plasma membrane levels of hCTR1 mediate cellular copper uptake. J. Biol. Chem., 280, 9635-9639 (2005)   DOI   ScienceOn
61 Pena, M. J. O., Puig, S., and Thiele, D. J., Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway. J. Biol. Chem., 275, 33244-33251 (2000)   DOI   ScienceOn
62 Aller, S. G., Eng, E. T., De Feo, C. J., and Unger, V. M., Eukaryotic Ctr copper uptake transporters require two faces of the third transmembrane domain for helix packing, oligomerization, and function. J. Biol. Chem., 279, 53435- 53441 (2004)   DOI   ScienceOn
63 Klomp, L. W., Lin, S. J., Yuan, D. S., Klausner, R. D., Culotta, V. C., and Gitlin, J. D., Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J. Biol. Chem., 272, 9221-9226 (1997)   DOI   ScienceOn
64 Puig, S., Lee, J., Lau, M., and Thiele, D. J., Biochemical and Genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake. J. Biol. Chem., 277, 26021-26030 (2002)   DOI   ScienceOn
65 Dobyan, D. C., Levi, J., Jacobs, C., Kosek, J., and Weiner, M. W., Mechanism of cis-platinum nephrotoxicity. II. Morphologic observations. J. Pharmacol. Exp. Ther., 213, 551–556 (1980)
66 Mishima, K., Baba, A., Matsuo, M., Itoh, Y., and Oishi, R., Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Rad. Biol. Med., 40, 1564-1577 (2006)   DOI   ScienceOn
67 Kapp, T., Muller, S., and Gust, R., Dinuclear Alkylamine Platinum( II) Complexes of [1,2-Bis(4-fluorophenyl)ethylenediamine] platinum(II): Influence of Endocytosis and Copper and Organic Cation Transport Systems on Cellular Uptake. Chem. Med. Chem., 1, 560-564 (2006)   DOI   ScienceOn
68 Klomp, A. E., Juijn, J. A., van der gun, L. T., van den Berg, I. E., Berger, R., and Klomp, L. W., The N-terminus of the human copper transporter 1 (hCTR1) is localized extracellularly, and interacts with itself. Biochem. J., 370, 881-889 (2003)   DOI   ScienceOn
69 Schondorf, T., Neumann, R., Benz, C., Riffelmann, M., Gohring, U. J., Sartorius, J., von Konig, C. H., Breidenbach, M., Valter, M. M., Hoopmann, M., Di Nicolantonio, F., and Kurbacher, C. M., Cisplatin, doxorubicin and packlitaxel induce mdr1 gene transcription in ovarian cancer cell lines. Recent Results Cancer Res., 161, 111-116 (2003)
70 Howell, S. B., Increased expression of ATP7A mediates platinum resistance. Clin. Cancer Res., 10, 4661-4669 (2004)   DOI   ScienceOn
71 Ikeda, K., Miura, K., Himeno, S., Imura, N., and Naganuma, A., Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum. Mol. Cell. Biochem., 219, 51- 56 (2001)   DOI   ScienceOn
72 Ooi, C. E., Rabinovich, E., Dancis, A., Bonifacino, J. S., and Klausner, R. D., Copper-dependent degradation of the Saccharomyces cerevisiae plasma membrane copper transporter Ctr1p in the apparent absence of endocytosis. EMBO. J., 15, 3515-3523 (1996)
73 Song, I. S., Savaraj, N., Siddik, Z. H., Liu, P., Wei, Y., Wu, C. J., and Kuo, M. T., Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatinsensitive and cisplatin-resistant cells. Mol. Cancer Ther., 3, 1543-1549 (2004)
74 Valko, M., Rhodes, C. J., Moncol, j., Izakovic, M., and Masur, M., Free radicals, metals and antioxidants in oxidative stressinduced cancer. Chemico-Biolog. Inter., 160, 1-40 (2006)   DOI   ScienceOn
75 Beretta, G. L., Gatti, L., Tinelli, S., Corna. E., Colangelo, D., Zunino, F., and Perego, P., Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells. Biochem. Pharmacol., 68, 283-291 (2004)   DOI   ScienceOn
76 Aller, S. G. and Unger, V. M., Projection structure of the human copper transporter CTR1 at 5-A resolution reveals a compact trimer with a novel channel-like architecture. Proc. Natl. Acad. Sci., 103, 3627-3632 (2006)
77 Pufahl, R. A., Singer, C. P., Peariso, K. L., Lin, S. J., Schmidt, P. J., Fahrni, C. J., Culotta, V. C., Penner-Hahn, J. E., and O'Halloran, T. V., Metal ion chaperone function of the soluble Cu(I) receptor Atox1. Science, 278, 853-856 (1997)   DOI